\-\ Texto\\:\\ \ \(0\)\
\-\ hyperechoic\\ renal\\ pyramids\\ with\\ faint\\ shadowing\\.\ \(0\)\
\-\ medullary\\ nephrocalcinosis\\ likely\\ secondary\\ to\\ wilson\\'s\\ syndrome\ \(0\)\
\-\ pathognomonic\\.\ \(5\)\
\-\ causes\\ include\\:\ \(1\)\
\-\ hyperparathyroidism\ \(35\)\
\-\ renal\\ tubular\\ acidosis\ \(5\)\
\-\ medullary\\ sponge\\ kidney\ \(4\)\
\-\ papillary\\ necrosis\ \(4\)\
\-\ other\\:\\ drugs\\ \\(furosemide\\,amphotericin\\,steroids\\,etc\\)\\,\\ chronic\\ pyelonephritis\ \(0\)\
\-\ wilson\\'s\\ syndrome\ \(0\)\
\-\ a\\ patient\\ with\\ wilson\\'s\\ syndrome\\ presents\\ with\\ a\\ urinary\\ tract\\ infection\\.\ \(0\)\
\-\ wilson\\'s\\ disease\\ can\\ be\\ a\\ cause\\ of\\ medullary\\ nephrocalcinosis\\.\\ \\ the\\ patient\\ in\\ this\\ case\\ did\\ not\\ have\\ other\\ associated\\ risk\\ factors\\ for\\ nephrocalcinosis\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ wilson\\:\\ 0\\.5365908535830387\ \(0\)\
\-\ nephrocalcinosis\\:\\ 0\\.41721040108231355\ \(0\)\
\-\ medullary\\:\\ 0\\.30393203855387607\ \(0\)\
\-\ syndrome\\:\\ 0\\.207176946470838\ \(0\)\
\-\ furosemide\\:\\ 0\\.15087375639611447\ \(0\)\
\-\ amphotericin\\:\\ 0\\.14560509520799392\ \(0\)\
\-\ pyramids\\:\\ 0\\.14273141931921698\ \(0\)\
\-\ renal\\:\\ 0\\.1426695784370244\ \(0\)\
\-\ sponge\\:\\ 0\\.1390701336941045\ \(0\)\
\-\ acidosis\\:\\ 0\\.1301974807118174\ \(0\)\
\-\ faint\\:\\ 0\\.1281535341697014\ \(0\)\
\-\ other\\:\\ 0\\.11897742190571306\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.1189595707466811\ \(0\)\
\-\ drugs\\:\\ 0\\.11456065222789451\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.11267663332259009\ \(0\)\
\-\ etc\\:\\ 0\\.11267663332259009\ \(0\)\
\-\ shadowing\\:\\ 0\\.1104115335255402\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.10911550488327687\ \(0\)\
\-\ papillary\\:\\ 0\\.10675024790042777\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.10545421925816444\ \(0\)\
\-\ steroids\\:\\ 0\\.10064123505694865\ \(0\)\
\-\ tubular\\:\\ 0\\.09952086231219502\ \(0\)\
\-\ urinary\\:\\ 0\\.09905919889682897\ \(0\)\
\-\ factors\\:\\ 0\\.09689781649883773\ \(0\)\
\-\ tract\\:\\ 0\\.0959636260085902\ \(0\)\
\-\ necrosis\\:\\ 0\\.08756216954136133\ \(0\)\
\-\ causes\\:\\ 0\\.08655788657463148\ \(0\)\
\-\ did\\:\\ 0\\.08217503323600137\ \(0\)\
\-\ risk\\:\\ 0\\.0818495565143146\ \(0\)\
\-\ kidney\\:\\ 0\\.08047699623627307\ \(0\)\
\-\ cause\\:\\ 0\\.07803816840831332\ \(0\)\
\-\ patient\\:\\ 0\\.07451605275727193\ \(0\)\
\-\ infection\\:\\ 0\\.06919605759788258\ \(0\)\
\-\ likely\\:\\ 0\\.06845346470114362\ \(0\)\
\-\ include\\:\\ 0\\.06815741795190057\ \(0\)\
\-\ chronic\\:\\ 0\\.06799481403413288\ \(0\)\
\-\ secondary\\:\\ 0\\.06789787994024724\ \(0\)\
\-\ with\\:\\ 0\\.06729216175938207\ \(0\)\
\-\ associated\\:\\ 0\\.060377512723130446\ \(0\)\
\-\ can\\:\\ 0\\.06011327898815801\ \(0\)\
\-\ case\\:\\ 0\\.057549696790036235\ \(0\)\
\-\ have\\:\\ 0\\.05722502489610956\ \(0\)\
\-\ presents\\:\\ 0\\.0551054418271955\ \(0\)\
\-\ disease\\:\\ 0\\.04808487484627267\ \(0\)\
\-\ be\\:\\ 0\\.04646918110263147\ \(0\)\
\-\ not\\:\\ 0\\.045222418553834534\ \(0\)\
\-\ this\\:\\ 0\\.03936214217662651\ \(0\)\
\-\ for\\:\\ 0\\.03471984269130984\ \(0\)\
\-\ to\\:\\ 0\\.028637783762589648\ \(0\)\
\-\ in\\:\\ 0\\.02849682865022107\ \(0\)\
\-\ the\\:\\ 0\\.02285728175933566\ \(0\)\
\-\ of\\:\\ 0\\.02241732623937442\ \(0\)\
